Alpelisib Completed Phase 1 Trials for Advanced and Selected Solid Tumors, AML, High Risk and Very High Risk MDS / Acute Myeloid Leukemia (AML) / High Risk and Very High Risk MDS / Advanced and Selected Solid Tumors Treatment